Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS®... Read more.
WELL Health Reports Record Patient Visits and Total Care Interactions in Q1 2025 and Provides Date for Earnings Event
WELL delivered more than 1.6 million patient visits in Q1 2025 representing system-wide YoY growth of 24% driven by organic growth of 14%. WELL Canada’s patient... Read more.
ConocoPhillips announces Bill Bullock to retire after 39 years with the company
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today announced that W.L. (Bill) Bullock, executive vice president and chief financial officer, will... Read more.
Predictmedix AI to Headline Exclusive European Investor Roadshow Across Budapest, Zagreb, and Belgrade
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading... Read more.
N-able Announces First Quarter 2025 Results
Delivers ARR Growth of ~11% Year-Over-Year on a Constant Currency Basis Exceeds First Quarter Revenue and Adjusted EBITDA Guidance Raises Mid-point of Full-Year... Read more.
International Seaways Reports First Quarter 2025 Results
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company,” “Seaways,” or “INSW”), one of the largest tanker companies... Read more.
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
Merck Animal Health unveils its largest economic development project in recent history RAHWAY, N.J.–(BUSINESS WIRE)–Merck Animal Health, known as MSD... Read more.
US Foods Reports First Quarter Fiscal Year 2025 Earnings
Grew Net Sales 4.5% to $9.4 Billion and Net Income 40.2% to $115 Million Grew Adjusted EBITDA 9.3% to $389 Million and Adjusted EPS 25.9% to $0.68 Reaffirms Full... Read more.
LumiThera’s LIGHTSITE IIIB Extension Trial Topline Results Show Extended Vision Improvement in Dry AMD Subjects
SEATTLE–(BUSINESS WIRE)–#DryAMD–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease,... Read more.
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic... Read more.